Abstract
Aim: To investigate whether acetazolamide, already found to be helpful in decreasing cystoid macular edema in patients with retinitis pigmentosa, was also effective in the treatment of diabetic macular edema in nonproliferative retinopathy. Methods:Two randomized age- and sex-matched groups (cases and controls) of 12 diabetics (five Type 1 and seven Type 2) were selected for this pilot study and graded for retinopathy (Early Treatment of Diabetic Retinopathy Study – Airlie House Classification). Cases were treated with acetazolamide for three months according to a standard protocol. The Early Treatment of Diabetic Retinopathy Study chart was used for assessing far-best corrected visual-acuity, and fluorescein angiography was performed using the Heidelberg Retina Angiograph. The Amsler grid-test and computerized-perimetry (Octopus 2000R) were also performed. Results: Fluorescein-angiographic findings and perimetric data improved significantly (p < 0.01) in the acetazolamide-treated cases compared to the controls while visual-acuity varied only slightly (p > 0.01). The Amsler grid-test resulted insignificant in our study (p > 0.05). No adverse effects or significant variations in laboratory tests were recorded. Conclusion: Further clinical investigations involving larger numbers of patients and a longer follow-up are required to confirm these preliminary results. However, the present study seems to suggest that acetazolamide could be effective in reducing fluorescein-angiographic findings and improving perimetric data in diabetics with macular edema, even though the mechanism of action remains obscure. Visual-acuity varied only slightly.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Farber MD, Lam S, Tessler HR. Jennings TJ, Cross A. Rusin, MM. Reduction of macular edema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective cross-over study. Br J Ophthalmol 1994; 78: 4-7.
Fishman GA, Gilbert LD, Anderson RJ, Marmor MF. Weleberg RG, Viana MA. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 1994; 101: 687-93.
Miyake Y, Awaya S, Takahashi H, Tomita N, Hirano K. Hyperbaric oxygen and acetazolamide improve visual acuity in patients with cystoid macular edema by different mechanisms. Arch Ophthalmol 1993; 111: 1605-6.
Fishman GA, Glenn AM., Gilbert LD. Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 1993; 111: 1640-6.
Grover S, Fishman GA, Fiscella RG, Adelman AE. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 1997; 17: 222-31.
Moss SE, Klein R, Klein BEK. The 14-year incidence of vision loss in a diabetic population. Ophthalmology 1998; 105: 998-1003.
Barly Treatment Diabetic Retinopathy Study Research Group. Farly photocoagulation for diabetic retinopathy ETDRS report No. 9. Ophthalmology 1991; 98: 766-85.
National Diabetes Data Group. Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
Mogensen CE, Schmitz O. The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North Am 1988; 72: 1465.
Pannarale L, Forte R, Giusti C, Vingolo EM. The effectiveness of acetazolamide in the treatment of diabetic macular edema. Proceedings of the Symposium on Vitreoretinal Diseases and Surgery-5th Biennial Schepens international Society Meeting 1995 March 1-5; Mexico City (Mexico): 111. Abstract.
Diabetic Retinopathy Study Research Group. Report 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981; 21: 210-26.
Trick GL, Trick LR, Kilo C. Visual field defects in patients with insulin-dependent and noninsulin-dependent diabetes. Ophthalmology 1990; 97: 475-82.
Nasrallah FP, Jalkh AB, Van Coppenolle F. The role of the vitreous in diabetic macular edema. Ophthalmology 1988; 95: 1335-9.
Moldow B, Sander B, Engler CB, Larsen M, Rosenberg T, Lund-Andersen H. The effect of acetazolamide on leakage and outward active transport of fluorescein across the bloodretina barrier in retinitis pigmentosa complicated by macular edema. Graefes Arch Clin Exp Ophthalmol 1998; 236: 881-9.
Lutjen-Drecoll E, Lonnerholm G, Eichorn M. Carbonic anhydrase distribution in the human and monkey eye by light and electron microscopy. Graefes Arch Clin Exp Ophthalmol 1983; 220: 285-91.
Marmor MF, Maack T. Enhancement of retinal adhesion and sub-retinal fluid resorption by acetazolamide. Invest Ophthalmol Vis Sci 1982; 23: 121-4.
Miller SS, Steinberg RH. Active transport of ions across frog retinal pigment epithelium. Exp Eye Res 1977; 25: 235-48.
Kawasaki K, Mukoh S, Yonemura D, Fujii S, Segawa Y. Acetazolamide-induced changes of the membrane potentials of the retinal pigment epithelial cell. Doc Ophthalmol 1986; 63: 375-81.
Hara Y, Tsuboi S. Takagi T. Effect of acetazolamide and mannitol on fluid movement across the blood-retina barrier in human subjects. Invest Ophthalmol Vis Sci 1988; 29: 404.
Moldow B, Sander B, Larsen M, Lund-Andersen H. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci 1999; 40: 1770-5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giusti, C., Forte, R., Vingolo, E.M. et al. Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. Int Ophthalmol 24, 79–88 (2001). https://doi.org/10.1023/A:1016354517304
Issue Date:
DOI: https://doi.org/10.1023/A:1016354517304